Bleeding in a COVID-19 Patient; Rectus Hematoma

Abstract

Anticoagulant therapy is part of the treatment of hospitalized COVID-19 patients. Low molecular weight heparin or oral anticoagulant drugs are used in its treatment. However this approach may increase the risks of bleeding. Rectus sheath hematoma (RSH) is a known complication of anticoagulant therapy and a source of potential morbidity and mortality. Here; we present a patient who developed rectus hematoma during the COVID-19 treatment and followed by us with conservative approach.

Keywords

• anticoagulation
• COVID-19
• rectus hematoma